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in A. albopictus–endemic areas of 
the country. The reported number of 
serologically proven cases probably 
underestimates the true extent of the 
diseases in Israeli travelers because 
underdiagnosis and underreporting 
are common. Both dengue and 
chikungunya virus infection result in 
viremia that may last up to 5 days, 
and viremic patients living in A. 
albopictus–endemic areas put the area 
population at risk for infection.
In summary, we report conditions 
in Israel suitable for autochthonous 
transmission of dengue and 
chikungunya viruses. Although 
no autochthonous cases have been 
reported in Israel, they have been 
reported from other countries where 
A. albopictus mosquitoes are newly 
endemic. In Israel and other areas 
where this species is newly endemic, 
both dengue and chikungunya virus 
infection should be considered in the 
differential diagnosis of acute febrile 
illnesses, even when the patients do 
not report recent travel to tropical 
areas. Enhanced surveillance may be 
needed to prevent epidemic spread 
of these diseases. Consideration 
must be taken to isolating suspected 
(viremic) dengue and chikungunya 
patients to prevent the establishment 
of autochthonous transmission.
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Possible 
Pet-associated 
Baylisascariasis 
in Child, Canada
To the Editor: Baylisascaris 
procyonis, a roundworm parasite 
of raccoons (Procyon lotor), 
increasingly is being documented as 
a cause of severe human disease (1). 
Approximately 130 species of wild 
and domesticated animals have been 
affected with B. procyonis neural 
larva migrans, and the parasite is 
increasingly recognized as a cause of 
human encephalitis (2; K. Kazacos, 
unpub. data). The fi rst recognized 
human case was reported in 1984 in a 
10-month-old child in Pennsylvania, 
USA (3). Since then, ≈30 additional 
cases of severe or fatal B. procyonis 
encephalitis have been reported in 
the United States (4–7; K. Kazacos, 
pers. comm.). To our knowledge, 
only 1 account of human B. procyonis 
infection has been reported in Canada 
(in 2009) (8). We report another case 
of human B. procyonis infection 
in Canada, indicating its probable 
transmission from peridomestic 
raccoons.
In 2008, a 14-month-old 
previously healthy boy in Hamilton, 
Ontario, Canada, sought care for 
fever, regression in speech for 5 days, 
and failure to bear weight for 2 days. 
His parents also noticed that he was 
not tracking with his eyes. Caregivers 
recalled a macular rash on the face 
and trunk that had faded over time. 
The child was hospitalized, and a 
workup for encephalitis was initiated. 
He was hemodynamically stable and 
had fl accid tone, with inability to bear 
weight. No visible rashes were found. A 
fundoscopic examination indicated no 
evidence of unilateral chorioretinitis. 
The child was unable to track objects, 
which suggested vision loss in both 
eyes. Blood cultures, urine cultures, 
and lumbar puncture were performed. 
Results of blood analyses showed the 
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following: lymphocytes 24% (45%–
76%), monocytes 41% (3%–6%), 
eosinophils 32% (0%–3%), protein 
34 g/L (42–74 g/L), and glucose 3.0 
mmol/L (3.3–5.8 mmol/L). Magnetic 
resonance imaging of the brain showed 
diffuse white matter lesions scattered 
in the subcortical and deep white 
matter over both cerebral hemispheres 
and periventricular region, most 
prominent in the left parietal lobe 
and frontoparietal regions, and subtle 
hyperintense lesions in bilateral 
dentate nucleus (Figure, panel A). No 
meningeal enhancement was noted.
Because of eosinophilic meningo-
encephalitis, thorough analyses were 
conducted for immunologic and 
infectious etiologies. The family 
confi rmed the presence of numerous 
raccoons in their backyard, which 
raised a concern for Baylisascaris 
encephalitis, and samples of 
cerebrospinal fl uid and serum were sent 
to Purdue University (West Lafayette, 
IN, USA) for serologic testing. On 
the basis of clinical fi ndings, the child 
was given albendazole 200 mg orally 
3×/day and prednisone 25 mg orally 
for 4 weeks. Results of ELISA were 
positive for B. procyonis from serum 
(optical density = 0.744; cutoff 0.250) 
but negative from cerebrospinal 
fl uid. B. procyonis–specifi c protein 
bands were seen on Western blotting 
(9). The parents reported that the 
child had no access to the backyard, 
but they and their dog often moved 
between the backyard and the 
house. Environmental sampling was 
conducted in conjunction with the 
public health department. Thirty 
samples were taken from the patient’s 
home and yard. A sample of raccoon 
feces taken from a garbage bag from 
the porch of the house contained 
embryonated B. procyonis eggs 
(Figure, panel B). No eggs were 
identifi ed in the dog. Nine months 
after the initial hospitalization, the 
child had substantial physical and 
motor delays, was legally blind in 
both eyes, and had epilepsy.
To our knowledge, this is 
the second case of Baylisascaris 
encephalitis identifi ed in Canada. Both 
cases are noteworthy for profound 
neurologic impairment. Similar to 
cases reported from the United States, 
the case reported here highlights the 
dangers of peridomestic raccoons, 
which are becoming increasingly 
common in both countries. Although 
the classical risk factors for pica/
geophagia or developmental delay 
were not reported by the patient’s 
parents, he could have become infected 
only through ingestion of infective 
eggs, from an as-yet-undetermined 
location, object, or source. The case 
reported here illustrates the need for 
a collaborative approach in unusual 
cases; we included clinicians and 
public health and laboratory specialists 
in the workup of this case. We found 
a strong correlation between the 
serologic fi ndings, the child’s clinical 
signs, other clinical information (e.g., 
eosinophilia, magnetic resonance 
imaging fi ndings), the age of the child, 
and the recovery of embryonated B. 
procyonis eggs from his environment. 
We postulate that he became infected 
by ingesting raccoon feces/infective 
eggs unintentionally brought into the 
home or through exposure in adjacent 
structures, such as the porch. Although 
no eggs were identifi ed in the dog, 
several reports have documented 
intestinal infection of domestic 
dogs with B. procyonis, albeit at a 
prevalence thousands of times lower 
than that in raccoons (3; J. Yang, 
unpub. data). That the dog served as a 
vector after being exposed to raccoon 
feces and infective eggs is far less 
likely. A recent report from the Centers 
for Disease Control and Prevention 
suggests possible transmission from 
pet kinkajous (10). We speculate that 
more common domestic pets also 
might serve as possible reservoirs for 
and sources of infection.
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Figure. A) Magnetic resonance imaging of the brain of a 14-month-old child with 
baylisascariasis encephalitis. B) Baylisascarasis procyonis embryonated egg found in wet 
preparation of raccoon feces; original magnifi cation ×100. A color version of this fi gure is 
available online (wwwnc.cdc.gov/EID/article/18/2/11-0674-F.htm).
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Zika Virus 
Infection, 
Cambodia, 2010
To the Editor: Zika virus (ZIKV), 
a member of the family Flaviviridae, 
genus Flavivirus, was fi rst isolated 
from the blood of a sentinel rhesus 
monkey from the Zika Forest of Uganda 
in 1948 (1). Since that time, serologic 
studies and virus isolations have 
demonstrated that the virus has a wide 
geographic distribution, including 
eastern and western Africa; the Indian 
subcontinent; Southeast Asia; and 
most recently, Micronesia (2–5). The 
virus is transmitted primarily through 
the bite of infected mosquitoes and 
most likely is maintained in a zoonotic 
cycle involving nonhuman primates 
(1), although recent evidence suggests 
the possibility of occasional sexual 
transmission in humans (4). Few case 
reports have described the clinical 
characteristics of ZIKV infection 
in humans. Most reports describe 
a self-limiting febrile illness that 
could easily be mistaken for another 
arboviral infection, such as dengue 
or chikungunya fever. We report a 
confi rmed case of ZIKV infection in 
Cambodia.
Since 2006, the US Naval Medical 
Research Unit No. 2 (NAMRU-2) has 
conducted surveillance for acute fever 
to determine causes of the infection 
among patients who seek health care 
at local clinics in Cambodia. Patients 
were enrolled by the health clinic 
physician after they gave informed 
consent in accordance with an 
institutional review board protocol 
approved by NAMRU-2 and the 
National Ethics Committee for Human 
Research of Cambodia. At enrollment, 
the physician administered a 
questionnaire and collected specimens 
(blood and throat swabs). All items 
were transported to the NAMRU-2 
laboratory in Phnom Penh, where 
testing was conducted for a variety 
of viral, bacterial, and parasitic 
pathogens. In August 2010, a blood 
specimen was collected from a 3-year-
old boy at a health clinic in Kampong 
Speu Province, Cambodia. The child’s 
reported clinical symptoms included 
4 days of fever and sore throat and 
cough and a headache for 3 days. A 
maculopapular rash was not observed, 
and the boy was not hospitalized. The 
clinic staff conducted a follow-up 
interview and reported that the patient 
recovered fully.
ZIKV infection was confi rmed in 
this patient by using PCR, sequencing, 
and serology and through virus 
isolation. ELISA for chikungunya and 
dengue virus IgM and IgG antibodies 
on acute- and convalescent-phase 
serum was negative. A universal 
fl avivirus real-time PCR screen that 
targets the nonstructural (NS) 5 gene 
(6) determined that the patient’s 
serum was positive for fl avivirus 
RNA, but subsequent species-specifi c 
PCR ruled out 2 other fl aviviruses 
that are highly endemic to the region 
(dengue and Japanese encephalitis 
viruses) (7–9). This result was the 
fi rst nondengue, non–Japanese 
encephalitis virus fl avivirus detected 
after samples from ≈10,000 enrolled 
patients were tested. Nucleic acid 
sequencing of the amplicon isolated 
by gel purifi cation produced a 100-
bp fragment with 100% sequence 
identity to ZIKV (nucleotide position 
8,969 of the NS5 gene of the isolate 
GenBank accession no. EU545988). 
ZIKV infection subsequently 
was serologically confi rmed by 
hemagglutination-inhibition tests on 
paired serum samples. The patient’s 
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